Cargando…
Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine
Autores principales: | De Groot, AS, Sangare, K, Koita, O, Ardito, M, Boyle, C, Levitz, L, Rozenhal, J, Tounkara, K, Dao, S, Kone, Y, Koty, Z, Moise, L, Martin, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441845/ http://dx.doi.org/10.1186/1742-4690-9-S2-P294 |
Ejemplares similares
-
Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
por: De Groot, AS, et al.
Publicado: (2012) -
A decade of partnering to stop HIV in West Africa: GAIA VF prevention, education, access to care and vaccine trial site development in Bamako, Mali
por: De Groot, A, et al.
Publicado: (2012) -
T cell epitope: Friend or Foe? Immunogenicity of biologics in context()
por: Weber, Constanze A., et al.
Publicado: (2009) -
Evaluating short-term patient outcomes after HIV care interventions in a low resource setting: preparing for an HIV vaccine trial site in Bamako, Mali
por: Koty, Z, et al.
Publicado: (2012) -
Immunogenic Consensus Sequence T helper Epitopes for a Pan-Burkholderia Biodefense Vaccine
por: De Groot, Anne S., et al.
Publicado: (2011)